|1.||Jonas, Jost B: 21 articles (05/2012 - 01/2003)|
|2.||Gillies, Mark C: 17 articles (01/2013 - 05/2003)|
|3.||Ramezani, Alireza: 13 articles (10/2014 - 09/2006)|
|4.||Ip, Michael S: 13 articles (02/2011 - 07/2004)|
|5.||Scott, Ingrid U: 11 articles (02/2015 - 10/2003)|
|6.||Yaseri, Mehdi: 11 articles (10/2014 - 11/2007)|
|7.||Soheilian, Masoud: 11 articles (10/2014 - 01/2007)|
|8.||Ahmadieh, Hamid: 10 articles (10/2014 - 09/2006)|
|9.||Bressler, Neil M: 10 articles (08/2013 - 09/2007)|
|10.||Diabetic Retinopathy Clinical Research Network: 10 articles (08/2013 - 06/2007)|
09/01/2007 - "Best-corrected visual acuity was found improved in patients with diabetic macular edema 5 months after triamcinolone injection. "
07/01/2008 - "By multivariate analysis, eyes treated with periocular triamcinolone had a significant reduction in the risk of radiation-induced macular edema (P = 0.002; hazard estimate = 0.49; 95% confidence interval, 0.17- 0.80). "
11/01/2004 - "Intravitreal triamcinolone application provides significant improvement in visual acuity of diabetic patients and clinical course of macular edema, and may therefore be a promising approach in the primary treatment of diabetic macular edema."
09/01/2004 - "To investigate the efficacy of intravitreal triamcinolone (IVT) by evaluation of pattern electroretinogram (PERG) in diabetic patients with clinically significant macular edema (CSME). "
09/01/2009 - "Intravitreal triamcinolone is superior to observation for treating vision loss associated with macular edema secondary to CRVO in patients who have characteristics similar to those in the SCORE-CRVO trial. "
01/01/2007 - "While 19 patients (73%) experienced almost complete pain relief, five of the remaining seven patients improved with intramuscular triamcinolone. "
09/01/2015 - "At 6 months, both groups had significantly improved mean pain and function scores, compared to the baseline scores; however, the mean pain and function scores in the 6-month HA + CS treatment group were better than in the 6-month triamcinolone group. "
09/01/2015 - "The mean pain and function scores for the HA + CS and triamcinolone groups had significantly improved at 3 months, but the mean function scores in the HA + CS group were statistically significantly better when compared to the triamcinolone group. "
12/01/2015 - "Both medications demonstrated improvement in subject reported pain but between group comparison at 4 weeks showed that triamcinolone was superior (P=0.044). "
10/01/2013 - "At 3 and 6 months, patients who received triamcinolone had higher effectiveness and improvement in pain during activities and pain at night than those of control group. "
|3.||Retinal Vein Occlusion
04/01/2009 - "The Standard Care versus COrticosteroid in REtinal Vein Occlusion (SCORE) Study includes 2 multicenter phase 3 randomized clinical trials evaluating the efficacy and safety of intravitreal triamcinolone: one involves participants with central retinal vein occlusion (CRVO) and one for participants with branch retinal vein occlusion (BRVO). "
12/01/2013 - "24 eyes of 24 patients (13 male and 11 female) with recent onset non-ischemic RVO (Retinal Vein Occlusion) underwent Posterior Sub-Tenon Triamcinolone (PSTT). "
04/01/2011 - "To evaluate the therapeutic effect of intravitreal triamcinolone (IVT) injection for recent branch retinal vein occlusion (BRVO). "
04/01/2011 - "Intravitreal triamcinolone for acute branch retinal vein occlusion: a randomized clinical trial."
12/01/2007 - "Decreased retinal vein diameter after intravitreal triamcinolone for retinal vein occlusions."
|4.||Pathologic Constriction (Stenosis)
12/01/2011 - "The goal of this study was to determine the efficacy of endoscopic triamcinolone injection (ETI) for the prevention of stricture formation after ESD. "
04/01/1999 - "The present study was conducted to determine the efficacy of intralesional triamcinolone in augmenting results of endoscopic dilation in corrosive esophageal strictures. "
11/01/2007 - "Balloon dilatation and triamcinolone were parts of a treatment regimen that improved clinical signs in the majority of dogs diagnosed with nonneoplastic rectal strictures."
12/01/2012 - "The present study was conducted to determine the effectiveness of intralesional triamcinolone to improve the results of endoscopic dilation in esophageal strictures. "
12/01/2012 - "We injected triamcinolone before dilating the strictures. "
|5.||Macular Degeneration (Age-Related Maculopathy)
02/01/2015 - "The apopto-phagocytic gene expression patterns during clearance of dying cells in the retina and the effect of triamcinolone (TC) upon these processes have relevance to development of age-related macular degeneration (AMD). "
06/01/2003 - "Possibly, intravitreal triamcinolone may be helpful for exudative age-related macular degeneration. "
01/01/2005 - "Analysis of longitudinal data from a randomized, double-masked, placebo-controlled trial of intravitreal triamcinolone for age-related macular degeneration (the Intravitreal Triamcinolone Study). "
11/01/2007 - "Prospective, randomized clinical trial of intravitreal triamcinolone treatment of neovascular age-related macular degeneration: one-year results."
09/01/2007 - "The aim of this prospective study was to investigate the effectiveness of sub-tenon application of triamcinolone for neovascular age-related macular degeneration. "
|8.||Adrenal Cortex Hormones (Corticosteroids)